500 patients67,039 observations150 daysLIVE

Patient P-03214

Synthetic patientONX-7 · Day 142 · 55–64 · F · baseline S18Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
35%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S18
  2. Day 13 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 18 DT-01 recommendedDosing / Timing Recommendation DT-01
  4. Day 19 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days
  • GI instability+15
  • Nutritional resilience-10
  • Inflammatory activity+9
  • Toxicity+6
  • Treatment adherence+5

What helped?

  • Dosing / Timing Recommendation DT-01Day 18
    Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
5.7/10
stable · +0.1 vs previous 14 d
Stress level
Daily log
3.7/10
improving · -0.2 vs previous 14 d
Pessimism score
Daily log
3.1/10
improving · -0.3 vs previous 14 d
Sleep quality
Wearable
47.8/100
worsening · -3.0 vs previous 14 d
Libido
Daily log
5.3/10
stable · +0.1 vs previous 14 d
HRV
Wearable
42.9 ms
stable · -0.8 vs previous 14 d
Toxicity
Blood
17.5/100
improving · -3.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 74 from the failing basin, 13 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -5.6 next day on high-intake days · n 24
Would not help
  • Keep histamine low
    GI +5.1 next day on high-intake days · n 21
  • Keep fat low
    GI +5 next day on high-intake days · n 19
  • Keep lactose low
    GI +3.7 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.6supporter · 95%
  • Histamine load
    +5.1detractor · 95%
  • Dietary fat load
    +5detractor · 95%
  • Lactose
    +3.7detractor · 94%
  • Caffeine
    -0.5no signal · 15%
  • Alcohol
    +0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 31/100
    • MicrobiomeF. prausnitzii depleted
  • Drug metabolism and exposure 35
    • DNADPYD *2A → slower clearance
  • Mucosal barrier integrity 30
    • DNAFUT2 non-secretor lowers mucosal fucosylation
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Intermediate metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.6 · butyrate capacity 31/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
48 ms
Sleep
6.2 h
Steps
8,695
Resting HR
59 bpm
Daily log: GI score 26, nutritional resilience 65, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0332852%S15GI-04improved59
P-0317946%S05GI-04improved52
P-0325246%S13SC-12improved68
P-0309745%S1660
P-0310745%S1762
P-0314445%S16HY-01improved52
P-0324645%S1561
P-0325545%S01HY-01improved53
P-0342045%S0859
P-0303344%S0566
P-0305744%S14NP-02improved64
P-0311244%S0662